目前，经导管动脉化疗(transcatheter arterial chemotherary，TAC)已广泛应用于临床并被证实可明显改善无法手术切除的中晚期PHC患者的生存质量。
基于1个网页-相关网页
目前，经导管动脉化疗(transcatheter arterial chemotherary，TAC)已广泛应用于临床并被证实可明显改善无法手术切除的中晚期PHC患者的生存质量。
基于1个网页-相关网页
经导管动脉化疗栓塞术 Transcatheter arterial chemoembolization ; t ransarterial chemoembolization
经导管动脉化疗栓塞 tran-scatheter arterial chemoembolization ; TACE
患者经导管动脉化疗 Transcatheter arterial chemotherapy
经导管肝动脉化疗栓塞 transcatheter arterial chemoembolization ; transcatheter hepatic arterial chemoembolization ; transcatheterhepaticarterialchemo embolization TACE ; transhepatic arterial chemoembolization
经导管肝动脉栓塞化疗 transcatheter arterial chemoembolization ; transcatheter arterial embotization ; TAE
经导管动脉栓塞化疗 transcatheter arterial chemoembolization ; TACE
经动脉导管栓塞化疗 transcatheter arterial chemembolization ; TACE
经导管动脉灌注化疗 transcatheter arterial infusion ; TAI
目的：探讨肝恶性肿瘤经导管动脉化疗栓塞术(TACE)后出现缺血性并发症的频次、治疗方法和预后。
Purpose: To evaluate the frequency, methods of treatment, and the outcome of ischemic complications after transcatheter arterial chemoembolization (TACE) in hepatic malignant tumors.
目的分析经导管肝动脉化疗栓塞术(TACE)及部分脾栓塞术(PSE)联合治疗对原发性肝癌(HCC)患者的肝功能影响。
Objective to evaluate the effect of transcatheter arterial chemoembolization (TACE) plus partial spleen embolization (PSE) on the liver function in patients with hepatocellular carcinoma (HCC).
目的探讨原发性肝癌经导管动脉栓塞化疗(TACE)术后的预后评估。
Objective To explore the prognostic evaluation of primary liver cancer after transcatheter arterial chemoembolization (TACE) operation.
应用推荐